Skip to main content
. Author manuscript; available in PMC: 2019 Jan 1.
Published in final edited form as: Adv Pharmacol. 2017 Oct 25;82:293–323. doi: 10.1016/bs.apha.2017.09.007

Fig. 2.

Fig. 2

Receptor signaling cascade-mediating Alzheimer's disease synapse damage by Aβ oligomers. Schematic illustrates the role of mGluR5 in linking cell surface Aβo–PrPC complexes to intracellular Fyn/Pyk2 and synaptic loss. Proteins are clustered in the PSD and alter NMDARs, calcium, and protein translation. Pyk2(PTK2B) variation is a verified genetic risk for late-onset AD. Tau plays a role in localizing Fyn. Aberrant PrPC–mGluR5–Fyn–Tau signaling leads to synaptic malfunction and loss.